3/25
04:01 am
bmrn
Jean-Jacques Bienaimé Appointed Chairman of the Board at Owkin [Yahoo! Finance]
Low
Report
Jean-Jacques Bienaimé Appointed Chairman of the Board at Owkin [Yahoo! Finance]
3/12
08:52 am
bmrn
New Data to be Presented for BioMarin's VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting [Yahoo! Finance]
Low
Report
New Data to be Presented for BioMarin's VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting [Yahoo! Finance]
3/12
08:30 am
bmrn
New Data to be Presented for BioMarin's VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
Low
Report
New Data to be Presented for BioMarin's VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
3/8
01:42 am
bmrn
Insider Sell: President, Worldwide R&D Henry Fuchs Sells 35,341 Shares of Biomarin ... [Yahoo! Finance]
Low
Report
Insider Sell: President, Worldwide R&D Henry Fuchs Sells 35,341 Shares of Biomarin ... [Yahoo! Finance]
3/7
08:41 am
bmrn
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer [Yahoo! Finance]
Low
Report
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer [Yahoo! Finance]
3/7
08:30 am
bmrn
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
Low
Report
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
3/1
09:18 am
bmrn
BioMarin Scheduled to Participate in March Investor Conferences [Yahoo! Finance]
Low
Report
BioMarin Scheduled to Participate in March Investor Conferences [Yahoo! Finance]
3/1
09:00 am
bmrn
BioMarin Scheduled to Participate in March Investor Conferences
Low
Report
BioMarin Scheduled to Participate in March Investor Conferences
2/29
10:55 am
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "hold" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $91.00 price target on the stock.
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "hold" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $91.00 price target on the stock.
2/27
12:21 am
bmrn
Decoding Biomarin Pharmaceutical Inc (BMRN): A Strategic SWOT Insight [Yahoo! Finance]
Low
Report
Decoding Biomarin Pharmaceutical Inc (BMRN): A Strategic SWOT Insight [Yahoo! Finance]
2/26
03:30 pm
bmrn
BioMarin Pharma gets DOJ subpoena on sponsored testing programs for two therapies [Reuters]
Low
Report
BioMarin Pharma gets DOJ subpoena on sponsored testing programs for two therapies [Reuters]
2/26
02:40 pm
bmrn
UPDATE 1-BioMarin Pharma gets DOJ subpoena on sponsored testing programs for two therapies [Yahoo! Finance]
Low
Report
UPDATE 1-BioMarin Pharma gets DOJ subpoena on sponsored testing programs for two therapies [Yahoo! Finance]
2/26
02:19 pm
bmrn
BioMarin Pharma gets DOJ subpoena on certain drug testing programs [Yahoo! Finance]
Low
Report
BioMarin Pharma gets DOJ subpoena on certain drug testing programs [Yahoo! Finance]
2/23
02:14 pm
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Piper Sandler from $115.00 to $107.00. They now have an "overweight" rating on the stock.
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Piper Sandler from $115.00 to $107.00. They now have an "overweight" rating on the stock.
2/23
01:09 pm
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $100.00 price target on the stock.
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $100.00 price target on the stock.
2/23
01:07 pm
bmrn
BioMarin (BMRN) Posts Q4 Earnings Beat, Upbeat Voxzogo Sales [Yahoo! Finance]
Low
Report
BioMarin (BMRN) Posts Q4 Earnings Beat, Upbeat Voxzogo Sales [Yahoo! Finance]
2/23
12:41 pm
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/23
10:56 am
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $100.00 price target on the stock.
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $100.00 price target on the stock.
2/22
07:54 pm
bmrn
Here's What Key Metrics Tell Us About BioMarin (BMRN) Q4 Earnings [Yahoo! Finance]
Low
Report
Here's What Key Metrics Tell Us About BioMarin (BMRN) Q4 Earnings [Yahoo! Finance]
2/22
07:02 pm
bmrn
BioMarin Pharmaceutical (BMRN) Beats Q4 Earnings and Revenue Estimates [Yahoo! Finance]
Low
Report
BioMarin Pharmaceutical (BMRN) Beats Q4 Earnings and Revenue Estimates [Yahoo! Finance]
2/22
04:50 pm
bmrn
BioMarin Pharmaceutical Inc. (BMRN) Announces Record Financial Results for 2023 [Yahoo! Finance]
Medium
Report
BioMarin Pharmaceutical Inc. (BMRN) Announces Record Financial Results for 2023 [Yahoo! Finance]
2/22
04:24 pm
bmrn
BioMarin Reports Record Financial Results for the Fourth Quarter and Full-year 2023 and Provides Financial Guidance for 2024 [Yahoo! Finance]
Low
Report
BioMarin Reports Record Financial Results for the Fourth Quarter and Full-year 2023 and Provides Financial Guidance for 2024 [Yahoo! Finance]
2/22
04:03 pm
bmrn
BioMarin Reports Record Financial Results for the Fourth Quarter and Full-year 2023 and Provides Financial Guidance for 2024
Low
Report
BioMarin Reports Record Financial Results for the Fourth Quarter and Full-year 2023 and Provides Financial Guidance for 2024
2/20
11:11 am
bmrn
Merus N.V. (MRUS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? [Yahoo! Finance]
Low
Report
Merus N.V. (MRUS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? [Yahoo! Finance]
2/19
11:08 am
bmrn
Seeking Clues to BioMarin (BMRN) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics [Yahoo! Finance]
Low
Report
Seeking Clues to BioMarin (BMRN) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics [Yahoo! Finance]